Navigation Links
Failing to bridge the gap between test tubes, animals, and human biology
Date:10/20/2011

Reasoning used in many highly cited cancer publications to support the relevance of animal and test tube experiments to human cancer is questionable, according to a study by researchers from Universit Libre de Bruxelles published in the open-access journal PLoS Computational Biology on October 20th 2011.

Most experimental biomedical research is performed on animals or on cells living in test tubes due to the limits ethics guidelines place on experimental investigation on humans. Bridging the gap between these experiments and human biology is a major hurdle. A connection is often made using the prognostic value of molecular markerssets of genes whose activation is related to particular biological processes. Researchers first determine a cancer marker and then assess the ability of the marker to predict survival. The fact that the marker is prognostic is considered to be evidence that the particular biological process is an important driver of cancer.

The authors question this reasoning by highlighting that most whimsical molecular markers, for example genes associated with mice social behavior, are prognostic in human breast cancer. Moreover, they studied 47 markers published in leading scientific journals, representing various biological processes supposedly relevant to breast cancer. They confirmed their prognostic value, but found that 60% of them are not better than random markers devoid of any biological rationale. Thus, the prognostic ability of molecular markers in human breast cancer seems to convey little meaningful information relevant to the biological processes of breast cancer progression.

The study recognizes that some molecular markers are truly prognostic and act as a useful guide to breast cancer treatment, even though they may fail to support the causal role of specific biological mechanisms in human breast cancer progression.


'/>"/>
Contact: Vincent Detours
vdetours@ulb.ac.be
32-255-54220
Public Library of Science
Source:Eurekalert

Page: 1

Related medicine news :

1. Psychiatrists failing to adequately monitor patients for metabolic side-effects of prescribed drugs
2. Schools failing pupils with sickle cell disease
3. U.S. Failing to Meet Goals for Womens Health: Report
4. FDA Failing to Monitor Safety of Medical Devices: Report
5. Jill Greenfield Comments on the Numerous Failings Highlighted by the Griffin Inquiry into Godstone Farm E.Coli 0157 Outbreak
6. Pew Report: Louisiana Failing to Address Childrens Dental Health Crisis
7. Pew Report: Pennsylvania Failing to Address Childrens Dental Health Crisis
8. Pew Report: New Jersey Failing to Address Childrens Dental Health Crisis
9. Pew Report: Florida Failing To Address Childrens Dental Health Crisis
10. NEJM Publishes Trial Results Demonstrating Bard FLAIR Endovascular Stent Graft Is Superior To Balloon Angioplasty For Failing Dialysis Grafts
11. Averting bridge disasters: New technology could save hundreds of lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement ... Vice President of North American Capital Sales at HTG Molecular . ... in the commercialization of the HTG EdgeSeq system and associated reagents in North America. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: